+373.4%
AMD vs GSK
+64.8%
+308.6%
-63.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +7.3% | -1.2% | +8.5% | +7.1% |
| 7D | +13.1% | -1.1% | +14.2% | +12.8% |
| 30D | -7.0% | +7.8% | -14.8% | -5.8% |
| 3M | +16.6% | +0.3% | +16.3% | +17.1% |
| 6M | +20.5% | +3.4% | +17.1% | +21.3% |
| YTD | +158.2% | +5.9% | +152.3% | +158.9% |
| 1Y | +132.8% | +8.2% | +124.6% | +133.2% |
| All | +373.4% | +64.8% | +308.6% | +418.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling